What is it about?
Cytomegalovirus (CMV) is one of the most widespread infections in the world and may play a role in atherosclerosis and thrombosis. We report a case of an immunocompetent young female patient who presented a pulmonary embolism associated with acute CMV infection without any other apparent cause of thrombosis.
Featured Image
Why is it important?
This is the first report of a pulmonary embolism associated with CMV treated with a direct oral anticoagulant (rivaroxaban). The current case report calls attention to the importance of signs and symptoms of thromboembolism among patients with CMV.
Perspectives
Direct oral anticoagulants can potentially bring the same benefits to treat pulmonary embolism associated with CMV as those observed in patients not infected. We believe this case report opens new perspectives to treat patients with CMV and thrombosis.
Dr Cesar de Almeida-Neto
Faculty of Medicine, University of São Paulo
Read the Original
This page is a summary of: Acute cytomegalovirus infection associated with pulmonary embolism treated successfully with rivaroxaban: case report, Journal of Thrombosis and Thrombolysis, October 2018, Springer Science + Business Media,
DOI: 10.1007/s11239-018-1758-3.
You can read the full text:
Contributors
The following have contributed to this page
